Results 11 to 20 of about 2,949,345 (236)
Let-7b microRNA and Sirtuin-1 mRNA gene expression as potential biomarkers for breast cancer Egyptian patients [PDF]
Ain Shams Medical Journal, 2023 Background and objectivesThe most frequently detected life-threatening malignancy in women is breast cancer. We aimed to evaluate Sirtuin-1 mRNA and let-7b microRNA gene expression in breast cancer patients in Egypt and to relate them with ...
Moatez Kamel +5 more
doaj +2 more sources
New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection
Chemosensors, 2022 Cancer antigen 15-3 (CA 15-3) is a biomarker for breast cancer used to monitor response to treatments and disease recurrence. The present work demonstrates the preparation and application of a fluorescent biosensor for ultrasensitive detection of the ...
Mariana P. Sousa +5 more
doaj +1 more source
Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
Asian Pacific Journal of Cancer Biology, 2022 Objectives: Breast cancer is the most common malignant tumor of females; the incidence increases with age. Bone is the most common site to which breast cancer metastasizes.
Julekha Khatun, Tarim Mahmood
doaj +1 more source
Diagnostics, 2023 Tumor marker determinations are valuable tools for the guidance of breast cancer patients during the course of disease. They are assessed on diverse analytical platforms that may be associated with differences according to the methods applied and the ...
Lars Schröder +9 more
doaj +1 more source
Cancer Treatment and Research Communications, 2021 Background: We aimed to evaluate the association of serum carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA 15–3) levels with clinicopathological parameters in patients with breast cancer (BC) and their efficiency for the prediction of ...
Meliha Melin Uygur, Mahmut Gümüş
doaj +1 more source
Case Reports in Oncology, 2021 A 73-year-old woman with no history of disease was referred to our hospital with fatigue and joint pain. Screening blood test showed that her cancer antigen 15-3 (CA 15-3) serum level was elevated to 36.6 U/mL, and a contrast-enhanced computed tomography
Koichiro Takayama +4 more
doaj +1 more source
Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
Frontiers in Oncology, 2023 BackgroundWithout organized screening programs up to 60-70% of breast cancers are diagnosed at advanced stages that have significantly lower five-year survival rate and poorer outcomes, which is a serious global public health problem.
Marina Sekacheva +4 more
doaj +1 more source
Tumor Markers in Dogs with Mammary Gland Tumors
Acta Veterinaria, 2023 The aim of this study was to determine and compare values of carcinoembryonic antigen (CEA) and cancer antigen (CA 15-3) in 50 bitches with mammary tumors and 150 clinically healthy dogs.
Valencakova Alexandra +4 more
doaj +1 more source
Performance Characteristics of Seven Automated CA 15-3 Assays [PDF]
American Journal of Clinical Pathology, 2006 Measurements of serum cancer antigen (CA) 15-3 are used to monitor tumor recurrence and treatment of advanced disease. We evaluated the performance characteristics, including limit of detection, linearity, method comparison, and reference intervals, of 7 automated methods for CA 15-3, including the Access 2 (Beckman Coulter, Brea, CA), ADVIA Centaur ...
Patricia R, Slev +2 more
openaire +2 more sources
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
BMC Cancer, 2012 Background Mucin-1 is known to be over-expressed by various human carcinomas and is shed into the circulation where it can be detected in patient’s serum by specific anti-Mucin-1 antibodies, such as the tumour marker assays CA 15–3 and CA 27.29.
Engelstaedter Verena +11 more
doaj +1 more source